Related Experiment Video

Updated: Aug 2, 2026

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents

D L Newton1, H J Hansen, H Liu

  • 1SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Room 162, Building 567, Frederick, MD 21702-1201, USA.

Critical Reviews in Oncology/Hematology
|June 22, 2001
PubMed

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling07:51

Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling

Published on: March 20, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...